CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

  • ID: 2559797
  • Report
  • Region: Italy
  • 287 pages
  • GlobalData
1 of 5
Italy’s Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

Summary

This new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Italian pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by a team of industry experts.

Italy’s population was 61.78 million in 2015, and is increasing due to a positive balance between the birth and death rates, as well as through immigration. The country’s policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the consumer price level (including Value Added Tax (VAT) and excluding hospital sales) was estimated at $22 billion in 2015, and is expected to decline to approximately $18 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 3.3%. The medical devices market was estimated at approximately $13.2 billion in 2015, and is expected to reach $16.2 billion by 2020, at a CAGR of 4.2%. The decline of Italy’s pharmaceutical market can primarily be attributed to -
- Owing to government measures to decrease healthcare expenditure
- Falling sales of patented drugs,
- Price cuts for drugs
- Government initiatives to promote generics
- The strict pricing of drugs through negotiations and through external reference pricing and internal reference pricing

Scope

The report provides information on Italy’s healthcare, regulatory and reimbursement landscape, and includes -
- An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Menarini, Angelini, Chiesi, Bracco and Recordati. The major players covered for the medical devices market are DePuy Synthes, GlaxoSmithKline (GSK), Baxter, Essilor and Siemens Healthcare
- An insightful review of the country’s reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
- Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Italy’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Italy’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
READ MORE
Note: Product cover images may vary from those shown
2 of 5
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Report Guidance

3 Overview of Pharmaceutical and Medical Device Markets

3.1 Pharmaceutical Market

3.1.1 Market Overview

3.1.2 Pharmaceutical Import and Export

3.1.3 Supply Channels

3.1.4 Market Segments

3.1.5 Major Therapeutic Areas

3.1.6 Major Companies

3.2 Medical Device Market

3.2.1 Market Overview

3.2.2 Overview of Top Five Segments

3.2.3 Diagnostic Market

3.2.4 Major Companies

3.3 Market Drivers and Barriers

3.3.1 Drivers

3.3.2 Barriers

4 Market Access

4.1 Reimbursement and Payer Landscape

4.1.1 Overview of Healthcare system

4.1.2 Evolution of Healthcare System in Italy

4.1.3 Reimbursement Process

4.1.4 Overview of Insurance Providers

4.1.5 Patient Share in Healthcare Spending

4.1.6 Price Trends in the Healthcare Sector

4.1.7 Pricing Policies

4.2 Regulatory Landscape

4.2.1 Overview of Regulatory Agencies

4.2.2 Market Authorization Procedure for Pharmaceutical Products

4.2.3 New Medical Device Approval Process

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5 Intellectual Property Rights

4.2.6 Clinical Trial Regulations

4.2.7 Pharmaceutical Advertising Regulations

4.2.8 Pharmacy Regulations

4.2.9 Labeling and Packaging Regulations

5 Country Analysis

5.1 Political Environment

5.1.1 Political Structure

5.1.2 Analysis of the Current Political Environment

5.1.3 Healthcare Policy Initiatives

5.2 Economic Landscape

5.3 Economic Indicators

5.3.1 Gross Domestic Product

5.3.2 Gross National Income

5.3.3 Inflation

5.3.4 Currency Exchange Rate

5.3.5 Foreign Direct Investment

5.3.6 Foreign Exchange Reserves

5.3.7 Trade Balance

5.3.8 Government Structural Balance

5.3.9 Government Net Debt

5.3.10 Major Industries

5.4 Demographics

5.4.1 Population

5.4.2 Education and Literacy

5.4.3 Employment

5.4.4 Disease Burden

5.5 Healthcare Infrastructure

5.5.1 Healthcare Facilities

5.5.2 Healthcare Parameters

5.5.3 Environmental Health

5.5.4 Healthcare Personnel

5.6 Healthcare Expenditure

5.6.1 Overview of Healthcare Expenditure

5.6.2 Major Components of Healthcare Expenditure

5.6.3 Healthcare Expenditure Distribution

5.6.4 Spending in Pharmaceutical R&D

5.7 Trade Associations

5.7.1 Pharmaceutical Industry Association

5.7.2 Farmindustria

5.7.3 Assogenerici

5.7.4 Confindustria

5.8 Trade Fairs

6 Opportunities and Challenges

6.1 Opportunities

6.2 Challenges

7 Appendix

7.1 Abbreviations

7.2 Bibliography

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasts

7.3.4 Expert Panel

7.4 Disclaimer

1.1 List of Tables

Table 1: Pharmaceutical Market, Italy, Revenue ($bn), 2008-2015

Table 2: Pharmaceutical Market, Italy, Revenue ($bn), 2016-2020

Table 3: Pharmaceutical Market, Italy, Imports and Exports ($bn), 2008-2015

Table 4: Pharmaceutical Distribution Channel, Italy, Price Margins (%), 2014

Table 5: OTC Market, Italy, Revenue ($bn) 2008-2015

Table 6: OTC Market, Italy, Revenue ($m) and Market Share (%) by Segment, 2014

Table 7: Pharmaceutical Market, Italy, Healthcare Costs by Therapeutic Area ($bn), 2014

Table 8: Menarini, Global, Major Products

Table 9: Menarini, Late-Stage Pipeline, 2014

Table 10: Angelini, Global, Major Products

Table 11: Angelini, Late-Stage Pipeline, 2016

Table 12: Chiesi, Global, Major Products

Table 13: Chiesi, Late-Stage Pipeline, 2014

Table 14: Bracco, Global, Major Products

Table 15: Recordati, Global, Major Products

Table 16: Recordati, Late-Stage Pipeline, 2016

Table 17: Medical Device Market, Italy, Revenue ($bn), 2008-2015

Table 18: Medical Device Market, Italy, Revenue ($bn), 2016-2020

Table 19: Medical Device Market, Italy, Revenue ($m) and Market Share (%) by Segment, 2015

Table 20: In Vitro Diagnostics Market, Italy, Revenue ($m), 2008-2015

Table 21: In Vitro Diagnostics Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2014

Table 22: Cardiovascular Device Market, Italy, Revenue ($m), 2008-2015

Table 23: Cardiovascular Disease Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2014

Table 24: Orthopedic Device Market, Italy, Revenue ($m), 2008-2015

Table 25: Orthopedic Devices Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2014

Table 26: Hospital Supplies Market, Italy, Revenue ($m), 2008-2015

Table 27: Hospital Supplies Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2014

Table 28: Nephrology and Urology Devices Market, Italy, Revenue ($m), 2008-2015

Table 29: Nephrology and Urology Devices Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2014

Table 30: Diagnostic Market, Italy, Revenue ($m), 2008-2015

Table 31: Diagnostic Market, Italy, Revenue ($m), 2016-2020

Table 32: Medical Device Market, Italy, Revenue ($m) and Market Shares (%) of Major Players, 2012

Table 33: GlaxoSmithKline, Global, Major Products, Revenue and Annual Growth, 2014

Table 34: Baxter, Global, Major Products, 2016

Table 35: Siemens Healthcare, Global, Major Products, 2015

Table 36: Market Access, Italy, Out-of-Pocket Expenditure (%), 2008-2015

Table 37: Market Access, Italy, Average Price Change (%), 2008-2015

Table 38: Patent Application Fee ($), Italy, 2016

Table 39: Election Results, Italy, February 2013

Table 40: Economic Indicators, Italy, Gross Domestic Product per Capita ($), 2008-2015

Table 41: Economic Indicators, Italy, Gross Domestic Product per Capita Forecast ($), 2016-2020

Table 42: Economic Indicators, Italy, Gross Domestic Product Annual Growth (%), 2008-2015

Table 43: Economic Indicators, Italy, Gross Domestic Product Annual Growth Forecast (%), 2016-2020

Table 44: Economic Indicators, Italy, Gross National Income per Capita ($), 2008-2014

Table 45: Economic Indicators, Italy, Average Consumer Price Index, 2008-2015

Table 46: Economic Indicators, Italy, Average Consumer Price Index, Forecast 2016-2020

Table 47: Economic Indicators, Italy, Average Consumer Price Annual Change (%), 2008-2015

Table 48: Economic Indicators, Italy, Currency Exchange Rate (€/$), 2008-2015

Table 49: Economic Indicators, Italy, Foreign Direct Investment ($bn), 2008-2014

Table 50: Economic Indicators, Italy, Foreign Exchange Reserves ($bn), 2008-2014

Table 51: Economic Indicators, Italy, Imports of Goods and Services ($bn), 2008-2014

Table 52: Economic Indicators, Italy, Exports of Goods and Services ($bn), 2008-2014

Table 53: Economic Indicators, Italy, Government Structural Balance ($bn), 2008-2015

Table 54: Economic Indicators, Italy, General Government Net Debt (% of GDP), 2008-2015

Table 55: Economic Indicators, Italy, General Government Net Debt, Forecast (% of GDP), 2016-2020

Table 56: Economic Indicators, Italy, Major Industries, Annual Change in Gross Value Added Per Hour Worked at Constant Prices (%), 2013 and 2015

Table 57: Demographics, Italy, Population (million), 2008-2015

Table 58: Demographics, Italy, Population Forecast (million), 2016-2020

Table 59: Demographics, Italy, Population, Urban and Rural Population Share (%), 2008-2015

Table 60: Demographics, Italy, Population, Urban and Rural Population Share, Forecast (%), 2016-2020

Table 61: Demographics, Italy, Population Distribution by Age Group (%), 2008-2015

Table 62: Demographics, Italy, Population Distribution by Age Group, Forecast (%), 2016-2020

Table 63: Demographics, Italy, Births (per 1,000 Population), 2008-2015

Table 64: Demographics, Italy, Mortality (per 1,000 Population), 2008-2015

Table 65: Demographics, Italy, Major Causes of Mortality, 2014

Table 66: Demographics, Italy, Children Under Five Years of Age, Mortality (per 1,000 Live Births), 2008-2015

Table 67: Demographics, Italy, Immunization Rate (%), 2008-2015

Table 68: Demographics, Italy, Major Causes of Male Mortality, 2014

Table 69: Demographics, Italy, Major Causes of Female Mortality, 2015

Table 70: Demographics, Italy, Gender Ratio (M/F), 2008-2015

Table 71: Demographics, Italy, Life Expectancy at Birth (Years), 2008-2015

Table 72: Demographics, Italy, Life Expectancy at Birth Forecast (Years), 2016-2020

Table 73: Demographics, Italy, Student Enrollment for School Education (%), 2013

Table 74: Demographics, Italy, Student Enrollment for University Education (%), 2012

Table 75: Demographics, Italy, Unemployment Rate (%), 2008-2015

Table 76: Demographics, Italy, Major Diseases, DALYs (per 1,000 Population), 2009

Table 77: Healthcare Infrastructure, Italy, Hospitals, 2008-2015

Table 78: Healthcare Infrastructure, Italy, Beds (per 1,000 Population) by Type of Service, 2008-2015

Table 79: Healthcare Infrastructure, Italy, Diagnostic Equipment (per Million Population), 2008-2015

Table 80: Healthcare Infrastructure, Italy, Hospital Beds (per 1,000 Population), 2008-2015

Table 81: Healthcare Infrastructure, Italy, Doctors (per 1,000 Population), 2008-2015

Table 82: Healthcare Infrastructure, Italy, PM2.5 emissions (µgm/m³ ), 2008-2015

Table 83: Healthcare Infrastructure, Italy, SOx Emissions (thousand tons), 2008-2015

Table 84: Healthcare Infrastructure, Italy, NOx Emissions (Thousand Tons), 2008-2015

Table 85: Healthcare Infrastructure, Italy, CO2 Emissions (Million Tons), 2008-2015

Table 86: Healthcare Infrastructure, Italy, General Practitioners (per 1,000 Population), 2008-2015

Table 87: Healthcare Infrastructure, Italy, Nurses (per 100,000 Population), 2008-2015

Table 88: Healthcare Infrastructure, Italy, Dentists (per 100,000 Population), 2008-2015

Table 89: Healthcare Infrastructure, Italy, Pharmacist (per 100,000 Population), 2008-2015

Table 90: Italy, Healthcare Expenditure (% of GDP), 2008-2015

Table 91: Healthcare Expenditure, Italy, Major Components of Healthcare Expenditure (%), 2008-2015

Table 92: Healthcare Expenditure, Italy, Public-Private Share (%), 2008-2015

Table 93: Healthcare Expenditure, Italy, Pharmaceutical R&D Expenditure ($bn), 2008-2015

Table 94: Major Healthcare Trade Fairs, Italy, 2016

1.2 List of Figures

Figure 1: Pharmaceutical Market, Italy, Revenue ($bn), 2008-2015

Figure 2: Pharmaceutical Market, Italy, Revenue ($bn), 2016-2020

Figure 3: Pharmaceutical Market, Italy, Imports and Exports ($bn), 2008-2015

Figure 4: Pharmaceutical Distribution Channel, Italy, Price Margins (%), 2014

Figure 5: OTC Market, Italy, Revenue ($bn) 2008-2015

Figure 6: OTC Market, Italy, Revenue by Segment ($m), 2014

Figure 7: Pharmaceutical Market, Italy, Healthcare Costs by Therapeutic Area ($bn), 2014

Figure 8: Medical Device Market, Italy, Revenue ($bn), 2008-2015

Figure 9: Medical Device Market, Italy, Revenue ($bn), 2016-2020

Figure 10: Medical Device Market, Italy, Revenue by Segment ($m), 2015

Figure 11: In Vitro Diagnostics Market, Italy, Revenue ($m), 2008-2015

Figure 12: In Vitro Diagnostics Market, Italy, Market Shares of Major Players (%) 2014

Figure 13: Cardiovascular Device Market, Italy, Revenue ($m), 2008-2015

Figure 14: Cardiovascular Disease Market, Italy, Market Shares of Major Players (%), 2014

Figure 15: Orthopedic Device Market, Italy, Revenue ($m), 2008-2015

Figure 16: Orthopedic Device Market, Italy, Market Shares of Major Players (%), 2014

Figure 17: Hospital Supplies Market, Italy, Revenue ($m), 2008-2015

Figure 18: Hospital Supplies Market, Italy, Market Shares of Major Players (%), 2014

Figure 19: Nephrology and Urology Devices Market, Italy, Revenue ($m), 2008-2015

Figure 20: Nephrology and Urology Devices Market, Italy, Market Shares of Major Players (%), 2014

Figure 21: Diagnostic Market, Italy, Revenue ($m), 2008-2015

Figure 22: Diagnostic Market, Italy, Revenue ($m), 2016-2020

Figure 23: Medical Device Market, Italy, Revenue of Major Players ($m), 2012

Figure 24: Healthcare Market, Italy, Drivers and Barriers, 2016

Figure 25: Market Access, Italy, Overview of Healthcare System

Figure 26: Market Access, Italy, Evolution of Healthcare System

Figure 27: Market Access, Italy, Pricing and Reimbursement Process for Pharmaceuticals, 2012

Figure 28: Market Access, Italy, Pricing and Reimbursement Process for Medical Devices in Hospital Setting, 2012

Figure 29: Market Access, Italy, Pricing and Reimbursement Process for Medical Devices in Ambulatory Setting, 2012

Figure 30: Market Access, Italy, Out-of-Pocket Expenditure (%), 2008-2015

Figure 31: Market Access, Italy, Average Price Change (%), 2008-2015

Figure 32: Market Access, Italy, National Procedure for Marketing Authorization, 2013

Figure 33: Market Access, Centralized Procedure for Market Authorization, Pre-submission, EU, 2013

Figure 34: Market Access, Centralized Procedure, Market Authorization, Pre-opinion Phase, EU, 2013

Figure 35: Market Access, Centralized Procedure, Market Authorization, Post-opinion Phase, EU, 2013

Figure 36: Market Access, Decentralized Procedure, Market Authorization, EU, 2013

Figure 37: Market Access, Decentralized Procedure, Market Authorization, EU, 2013

Figure 38: Market Access, Conformity Assessment of Class I Medical Devices, EU, 2013

Figure 39: Market Access, Conformity Assessment of Class IIa Medical Devices, EU, 2013

Figure 40: Market Access, Conformity Assessment of Class IIb Medical Devices, EU, 2013

Figure 41: Market Access, Conformity Assessment of Class III Medical Devices, EU, 2013

Figure 42: Market Access, Licensing Process for Manufacturing, Italy, 2011

Figure 43: Market Access, Patent Approval Process, Italy, 2011

Figure 44: Market Access, Patent Approval Process, Italy, 2011

Figure 45: Political Structure, Italy

Figure 46: Economic Indicators, Italy, Gross Domestic Product per Capita ($), 2008-2015

Figure 47: Economic Indicators, Italy, Gross Domestic Product per Capita Forecast ($), 2016-2020

Figure 48: Economic Indicators, Italy, Gross Domestic Product Annual Growth (%), 2008-2015

Figure 49: Economic Indicators, Italy, Gross Domestic Product Annual Growth Forecast (%), 2016-2020

Figure 50: Economic Indicators, Italy, Gross National Income per Capita ($), 2008-2014

Figure 51: Economic Indicators, Italy, Average Consumer Price Index, 2008-2015

Figure 52: Economic Indicators, Indonesia, Average Consumer Price Index Forecast, 2016-2020

Figure 53: Economic Indicators, Italy, Average Consumer Price Annual Change (%), 2008-2015

Figure 54: Economic Indicators, Italy, Currency Exchange Rate (€/$), 2008-2015

Figure 55: Economic Indicators, Italy, Foreign Direct Investment ($bn), 2008-2014

Figure 56: Economic Indicators, Italy, Foreign Exchange Reserves ($bn), 2008-2014

Figure 57: Economic Indicators, Italy, Imports of Goods and Services ($bn), 2008-2014

Figure 58: Economic Indicators, Italy, Exports of Goods and Services ($bn), 2008-2014

Figure 59: Economic Indicators, Italy, Government Structural Balance ($bn), 2008-2015

Figure 60: Economic Indicators, Italy, General Government Net Debt (% of GDP), 2008-2015

Figure 61: Economic Indicators, Italy, General Government Net Debt Forecast (% of GDP), 2016-2020

Figure 62: Economic Indicators, Italy, Major Industries, Annual Change in Gross Value Added Per Hour Worked at Constant Prices (%), 2013 and 2015

Figure 63: Demographics, Italy, Population (million), 2008-2015

Figure 64: Demographics, Italy, Population Forecast (million), 2016-2020

Figure 65: Demographics, Italy, Population, Urban and Rural Population Share (%), 2008-2015

Figure 66: Demographics, Italy, Population, Urban and Rural Population Share Forecast (%), 2016-2020

Figure 67: Demographics, Italy, Population Distribution by Age Group (%), 2008-2015

Figure 68: Demographics, Italy, Population Distribution by Age Group, Forecast (%), 2016-2020

Figure 69: Demographics, Italy, Births (per 1,000 Population), 2008-2015

Figure 70: Demographics, Italy, Mortality (per 1,000 Population), 2008-2015

Figure 71: Demographics, Italy, Major Causes of Mortality (‘000), 2014

Figure 72: Demographics, Italy, Children Under Five Years of Age, Mortality (per 1,000 Live Births), 2008-2015

Figure 73: Demographics, Italy, Immunization Rate (%), 2008-2015

Figure 74: Demographics, Italy, Major Causes of Male Mortality (‘000), 2014

Figure 75: Demographics, Italy, Major Causes of Female Mortality (‘000), 2014

Figure 76: Demographics, Italy, Gender Ratio (M/F), 2008-2015

Figure 77: Demographics, Italy, Life Expectancy at Birth (Years), 2008-2015

Figure 78: Demographics, Italy, Life Expectancy at Birth Forecast (Years), 2016-2020

Figure 79: Demographics, Italy, Student Enrollment for School Education (%), 2013

Figure 80: Demographics, Italy, Student Enrollment for University Education (%), 2012

Figure 81: Demographics, Italy, Unemployment Rate (%), 2008-2015

Figure 82: Demographics, Italy, Major Diseases, DALYs (per 1,000 Population), 2009

Figure 83: Healthcare Infrastructure, Italy, Hospitals, 2008-2015

Figure 84: Healthcare Infrastructure, Italy, Beds (per 1,000 Population) by Type of Service, 2008-2015

Figure 85: Healthcare Infrastructure, Italy, Diagnostic Equipment (per Million Population), 2008-2015

Figure 86: Healthcare Infrastructure, Italy, Hospital Beds (per 1,000 Population), 2008-2015

Figure 87: Healthcare Infrastructure, Italy, Doctors (per 1,000 Population), 2008-2015

Figure 88: Healthcare Infrastructure, Italy, PM2.5 emissions (µgm/m³), 2008-2015

Figure 89: Healthcare Infrastructure, Italy, SOx Emissions (Thousand Tons), 2008-2015

Figure 90: Healthcare Infrastructure, Italy, NOx Emissions (Thousand Tons), 2008-2015

Figure 91: Healthcare Infrastructure, Italy, CO2 Emissions (Million Tons), 2008-2015

Figure 92: Healthcare Infrastructure, Italy, General Practitioners (per 1,000 Population), 2008-2015

Figure 93: Healthcare Infrastructure, Italy, Nurses (per 100,000 Population), 2008-2015

Figure 94: Healthcare Infrastructure, Italy, Dentists (per 100,000 Population), 2008-2015

Figure 95: Healthcare Infrastructure, Italy, Pharmacist (per 100,000 Population), 2008-2015

Figure 96: Italy, Healthcare Expenditure (% of GDP), 2008-2015

Figure 97: Healthcare Expenditure, Italy, Major Components Of Healthcare Expenditure (%), 2008-2015

Figure 98: Healthcare Expenditure, Italy, Public-Private Share (%), 2008-2015

Figure 99: Healthcare Expenditure, Italy, Pharmaceutical R&D Expenditure ($bn), 2008-2015

Figure 100: Healthcare Market, Italy, Opportunities and Challenges, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Italy’s Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy.

The pharmaceutical industry in Italy is set to decline from $21.3 billion in 2016 to $18.6 billion by 2020, at a negative compound annual growth rate of 3.3%, primarily due to the country’s struggling economy.

The company’s latest report* states that the strict pricing of drugs through negotiations and external and internal reference pricing is a barrier to the launch of innovative molecules, and that sales of generics and over-the-counter drugs will increase over the forecast period.

Adam Dion, MSc, Senior Industry Analyst, explains: “The pharmaceutical industry in Italy will face a number of challenges over the next few years. An increase in the Italian government’s debt relative to GDP, and the country’s poor growth record, will decrease cash flow in the country, meaning the industry will stagnate."

The Italian economy is also vulnerable to fluctuations in the demand and supply of goods and services in other countries. The Eurozone crisis is likely to result in lower demand for Italian products from other European countries, reducing exports and engendering a hostile environment for innovation or investment. India and China also present a threat as they have an edge in the generics market, and may usurp sales away from Italy’s domestic pharmaceutical space.

Dion concludes: “Despite the tough economic environment faced by those operating within the Italian pharmaceutical industry, the report believes there will be a number of opportunities to counteract declining sales, including efficient patent policies, E-Health programs, and government reforms to reduce public debt. Indeed, more companies will be interested in research and development after the Italian Patent and Trademark Office has created efficient patent policies to protect them.”

*CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

This report provides analysis of the pharmaceutical market in Italy, and the impact of the current and emerging market access strategies used by the pharmaceutical industry for new and existing drugs. It includes annualized market data from 2015 and forecast to 2020, and discusses the regulatory requirements, key health insurance trends, recent government healthcare reforms, and general industry trends.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by a team of industry experts.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll